3 mL (Syringe Volume) Segment has the Largest Share of Product in the Asia Pacific Arterial Blood Gas Kits Market during 2021–2028
According to The Insight Partners market research study on “Asia Pacific Arterial Blood Gas Kits Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, and End User” is expected to reach US$ 171.1 million by 2028 from US$ 98.3 million in 2021. The market is estimated to grow at a CAGR of 8.2% from 2021 to 2028. The report provides trends prevailing in the Asia Pacific Arterial blood gas kits market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing prevalence of respiratory diseases and growing prevalence of metabolic and kidney diseases are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the challenges such as risks, complications, and sampling errors associated with arterial blood sampling.
Growing research on arterial blood gas analysis in COVID 19 patients is likely to have positive impact on the market. For instance, ‘Arterial Blood Gas Analysis of Critically Ill Corona Virus Disease 2019 Patients’ was published in Asian Journal of Research in Infectious Diseases in April 2021. The study concluded that ABG test performed on critically ill COVID-19 patients gives valuable information on underlying pathophysiology. Thus, increasing government support and useful information offered by ABG tests in COVID-19 patients are expected to support the region's arterial blood gas kits market.
The market for arterial blood gas kits market is segmented into product, and end user. Based on product, the arterial blood gas kits market is segmented into 1 mL, 3 mL, and other syringe volumes. In 2021, the 3 ml segment accounted for the largest share of the market and accounted for the highest CAGR. Innovative products offered by the market players operating in this space is likely to favour market growth of this segment. For instance, Pro-Vent Plus 3 mL Arterial Blood Sampling syringes by Smith Medical uses lithium heparin with a concentration of 23.5 I.U. per mL. The specially formulated dry lithium heparin offers the necessary anticoagulation along with minimal interference for more accurate results.
Becton Dickinson and Company, Radiometer Medical ApS, Smiths Medical, Vyaire Medical, Opti Medical Systems, Inc., Westmed Medical, Siemens Healthineers AG, ITL Biomedical, i-SENS, Inc., and Teleflex Incorporated are among the leading companies in the Asia Pacific arterial blood gas kits market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in April 2020, Teleflex Incorporated and Premier, a leading healthcare improvement company has signed partnership agreement to improve market utilization of Teleflex's Arrow Brand vascular access products.
The market for arterial blood gas kits market is segmented into product, and end user. Based on product, the arterial blood gas kits market is segmented into 1 mL, 3 mL, and other syringe volumes. Based on end user, the arterial blood gas kits market is segmented into hospitals, clinics, and others. Geographically, the arterial blood gas kits market is segmented into Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia Pacific).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com